Period13 Mar 2024

Media coverage

1

Media coverage

  • TitleFDA delays approval of Alzheimer's drug donanemab: What experts think
    Media name/outletMedical News Today
    Country/TerritoryUnited Kingdom
    Date13/03/24
    PersonsHoward Fillit